{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:12:42Z","timestamp":1790493162713,"version":"4.1.0"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.18632\/aging.202328","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T17:44:35Z","timestamp":1611337475000},"page":"3645-3660","source":"Crossref","is-referenced-by-count":17,"title":["Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas"],"prefix":"10.18632","volume":"13","author":[{"given":"Li","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China"},{"name":"Tianjin Neurological Institute, Tianjin 300052, China"},{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Solna 17164, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China"},{"name":"Tianjin Neurological Institute, Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China"},{"name":"Tianjin Neurological Institute, Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China"},{"name":"Tianjin Neurological Institute, Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Solna 17164, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Nist\u00e9r","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Solna 17164, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China"},{"name":"Tianjin Neurological Institute, Tianjin 300052, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015.","volume":"2","author":"Barnholtz-Sloan","year":"2018","journal-title":"Neuro Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"35","author":"Ludwin","year":"2005","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrneurol.2017.54","article-title":"Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.","volume":"1","author":"Jenkins","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"4","doi-asserted-by":"publisher","first-page":"eaal2463","DOI":"10.1126\/scitranslmed.aal2463","article-title":"2-hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.","volume":"9","author":"Mishra-Gorur","year":"2017","journal-title":"Sci Transl Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary.","volume":"13","author":"Ellison","year":"2016","journal-title":"Acta Neuropathol"},{"key":"6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccell.2015.06.014","article-title":"Genetic classification of gliomas: refining histopathology.","volume":"2","author":"Diaz","year":"2015","journal-title":"Cancer Cell"},{"key":"7","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors.","volume":"37","author":"Kollmeyer","year":"2015","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/neuonc\/nov136","article-title":"Isocitrate dehydrogenase mutations in gliomas.","volume":"1","author":"Yan","year":"2016","journal-title":"Neuro Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","article-title":"Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation.","volume":"1","author":"Dubrovskyi","year":"2017","journal-title":"Cell Rep"},{"key":"10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/neuonc\/nox042","article-title":"Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.","volume":"1","author":"Zhou","year":"2017","journal-title":"Neuro Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/neuonc\/nox078","article-title":"Adult IDH wild-type lower-grade gliomas should be further stratified.","volume":"1","author":"Ng","year":"2017","journal-title":"Neuro Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"17740","DOI":"10.1038\/s41598-017-17062-1","article-title":"BCAT1 is a new MR imaging-related biomarker for prognosis prediction in IDH1-wildtype glioblastoma patients.","volume":"7","author":"Choi","year":"2017","journal-title":"Sci Rep"},{"key":"13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0350-z","article-title":"Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism.","volume":"5","author":"Son","year":"2019","journal-title":"Exp Mol Med"},{"key":"14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","article-title":"Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation.","volume":"9","author":"Lyu","year":"2019","journal-title":"Cancer Discov"},{"key":"15","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/onc.2017.32","article-title":"The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ER\u03b1-negative breast cancer.","volume":"3","author":"Kneisel","year":"2017","journal-title":"Oncogene"},{"key":"16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.celrep.2019.06.026","article-title":"Branched-chain amino acid metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors.","volume":"2","author":"Jiang","year":"2019","journal-title":"Cell Rep"},{"key":"17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/his.12778","article-title":"BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.","volume":"6","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","article-title":"BCAT1 restricts \u03b1KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.","volume":"55","author":"Przybylla","year":"2017","journal-title":"Nature"},{"key":"19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm.3217","article-title":"BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.","volume":"1","author":"Lemke","year":"2013","journal-title":"Nat Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","article-title":"Transaminase inhibition by 2-hydroxyglutarate impairs glutamate biosynthesis and redox homeostasis in glioma.","volume":"17","author":"Parker","year":"2018","journal-title":"Cell"},{"key":"21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41598-018-37390-0","article-title":"assessment of increased oxidation of branched-chain amino acids in glioblastoma.","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"key":"22","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/neuonc\/nox054","article-title":"Correlation of immune phenotype with IDH mutation in diffuse glioma.","volume":"1","author":"Preusser","year":"2017","journal-title":"Neuro Oncol"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Genetic and Epigenetic Mechanisms Promote IDH1-Mutant Glioma Progression. Cancer Discov. 2016; 6:OF14-OF14. https:\/\/doi.org\/10.1158\/2159-8290.CD-RW2015-232.","DOI":"10.1158\/2159-8290.CD-RW2015-232"},{"key":"24","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1158\/1078-0432.CCR-14-0238","article-title":"Definition of primary and secondary glioblastoma\u2014response.","volume":"2","author":"Kleihues","year":"2014","journal-title":"Clin Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ng.3457","article-title":"Integrated genomic characterization of IDH1-mutant glioma malignant progression.","volume":"4","author":"Carri\u00f3n-Grant","year":"2016","journal-title":"Nat Genet"},{"key":"26","doi-asserted-by":"crossref","unstructured":"IDH inhibitors target common glioma mutation. Cancer Discov. 2019; 9:992. https:\/\/doi.org\/10.1158\/2159-8290.CD-ND2019-007.","DOI":"10.1158\/2159-8290.CD-ND2019-007"},{"key":"27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.","volume":"34","author":"Schalm","year":"2013","journal-title":"Science"},{"key":"28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","article-title":"Biological role and therapeutic potential of IDH mutations in cancer.","volume":"3","author":"Yan","year":"2018","journal-title":"Cancer Cell"},{"key":"29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/neuros\/nyy338","article-title":"Loss of BCAT1 expression is a sensitive marker for IDH-mutant diffuse glioma.","volume":"8","author":"Ho","year":"2019","journal-title":"Neurosurgery"},{"key":"30","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.15252\/embr.201744154","article-title":"Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype.","volume":"1","author":"Radlwimmer","year":"2017","journal-title":"EMBO Rep"},{"key":"31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/bpa.12385","article-title":"Decreased expression of the mitochondrial BCAT protein correlates with improved patient survival in IDH-WT gliomas.","volume":"2","author":"Kurian","year":"2016","journal-title":"Brain Pathol"},{"key":"32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11060-016-2073-5","article-title":"Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.","volume":"12","author":"Nghiemphu","year":"2016","journal-title":"J Neurooncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.","volume":"1","author":"Nishikawa","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.","volume":"6","author":"Xu","year":"2019","journal-title":"Gut"},{"key":"35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40425-018-0452-5","article-title":"Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.","volume":"6","author":"Fox","year":"2018","journal-title":"J Immunother Cancer"},{"key":"36","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/2326-6066.CIR-17-0537","article-title":"Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and activation.","volume":"6","author":"Dow","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in Tcell-mediated tumor immunoevasion.","volume":"2","author":"Termentzi","year":"2020","journal-title":"Nat Immunol"},{"key":"38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","article-title":"Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12\/CXCR4.","volume":"3","author":"Yang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1002\/ctm2.130","article-title":"IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3\/PD-L1 pathway.","volume":"1","author":"Yang","year":"2020","journal-title":"Clin Transl Med"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:12:06Z","timestamp":1617725526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,15]]}},"alternative-id":["202328","33493139"],"URL":"https:\/\/doi.org\/10.18632\/aging.202328","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]}}}